These monoclonal antibodies are useful for immuno-detection in environmental monitoring and worker exposure applications.
[Detail]
May increase efficacy of GBM treatmentsNon-toxic to healthy cells; reduces comorbiditiesTargets slow-dividing stem cells as opposed to rapid-dividing cells (i.e. chemotherapies)
[Detail]
Feature selection and tracking are performed in real-time Improved baseline algorithms in terms of performance accuracy and robustness Lower computational costs
[Detail]
| |< <- | [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] | -> >| |
